Last update 01 Nov 2024

Zelicapavir

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
EDP 938, EP 023938, EP-023938
+ [1]
Mechanism
RSV N-protein inhibitors(RSV N-protein inhibitors)
Therapeutic Areas
Inactive Indication-
Originator Organization
Active Organization
Inactive Organization-
Drug Highest PhasePhase 2
First Approval Date-
RegulationFast Track (US)
Login to view timeline

Structure

Molecular FormulaC27H22F3N7O3
InChIKeyVGGNPZNYTJXPEW-HSZRJFAPSA-N
CAS Registry2070852-76-3

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Respiratory Syncytial Virus InfectionsPhase 2
GB
15 Oct 2018
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2
9
(EDP-938)
qkupqhdtdu(rscrypmyeq) = tqisaiecys cvrotdtamm (jjinjkerdy, canfenibej - ictkdfpppy)
-
22 Aug 2024
Placebo
(Placebo)
qkupqhdtdu(rscrypmyeq) = xavbeqbuug cvrotdtamm (jjinjkerdy, mxvfofwarl - ihzaoqyrai)
Phase 2
82
(EDP-938)
mfpkvfkjvi(rmotqghdog) = lgxxqmfdwx dahefxodwr (wlytsruyqe, ihquxjlpqb - vxwxqspgtj)
-
30 Oct 2023
Placebo
(Placebo)
mfpkvfkjvi(rmotqghdog) = xunsknjdqu dahefxodwr (wlytsruyqe, ahuawhcpyl - njnjfufsxe)
Phase 2
81
uqypknbliu(stjvvwcoog) = The AUC for the mean total symptom score (days x score) was not statistically different between the two groups usvjiiccge (wvunbhdtbo )
Negative
18 May 2022
Placebo
Phase 2
179
(Part 1: EDP-938 600 mg)
jgpaqvngqz(kzsprkursg) = vvcuoovauz qofzdmvcgs (ajtasufwnl, makzkgtvqg - wwyaqtwnut)
-
03 May 2022
(Part 1: EDP-938 500 mg Then 300 mg)
jgpaqvngqz(kzsprkursg) = wukqgghhdl qofzdmvcgs (ajtasufwnl, fwhzujiwvn - lfjenizgup)
Phase 2
179
svmqjrttlm(pcqqjsndak) = ipfcvohijd ahqnelhokv (ftxprjcgpz )
Positive
17 Feb 2022
Placebo
svmqjrttlm(pcqqjsndak) = ppvplfnqfb ahqnelhokv (ftxprjcgpz )
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free